https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-lilly-see-insatiable-demand-weight-loss-drugs-2023-11-02/
0
0
11/2/23 at 5:17pm
Organization
Reuters
Novo Nordisk <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> and Eli Lilly <a href="https://www.reuters.com/markets/companies/LLY.N" target="_blank">(LLY.N)</a> both expect juggernaut sales for their diabetes and we…
Create an account
or login to join the discussion